Clinical Trial Update: A Study of Escalating Doses of Itacitinib Administered Orally in Patients With Plaque Psoriasis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating escalating oral doses of itacitinib in patients with plaque psoriasis; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• Itacitinib (itacitinib)

Snippet

Sponsor: Incyte Corporation | Conditions: Plaque Psoriasis | Phase 2 | Status: COMPLETED